Antagonist of Growth Hormone-Releasing Hormone Receptor MIA-690 Suppresses the Growth of Androgen-Independent Prostate Cancers
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252011200 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Laura Muñoz-Moreno und 6 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Investigación Cánceres de Origen Epitelial, Departamento de Biología de Sistemas, Campus Científico-Tecnológico, Universidad de Alcalá, 2880…. Hauptthemen laut MEDLINE: Mice, Nude, Gefitinib, Receptors, Pituitary Hormone-Regulating Hormone. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, European Regional Development Fund, Medical Research Service of the Department of U.S. Veterans Affairs.
Abstract (Originalsprache)
The development of resistance remains the primary challenge in treating castration-resistant prostate cancer (CRPC). GHRH receptors (GHRH-R), which are coupled to G-proteins (GPCRs), can mediate EGFR transactivation, offering an alternative pathway for tumour survival. This study aimed to evaluate the effects of the GHRH-R antagonist MIA-690, in combination with the EGFR inhibitor Gefitinib, on cell viability, adhesion, gelatinolytic activity, and the cell cycle in advanced prostate cancer PC-3 cells. The findings demonstrate a synergistic effect between MIA-690 and Gefitinib, leading to the inhibition of cell viability, adhesion, and metalloprotease activity. Cell cycle analysis suggests that both compounds induce cell cycle arrest, both individually and in combination. Furthermore, similar effects of the GHRH-R antagonist MIA-690 combined with Gefitinib were observed in PC-3 tumours developed by subcutaneous injection in athymic nude mice 36 days post-inoculation. These results indicate that combined therapy with a GHRH-R antagonist and an EGFR inhibitor exerts a stronger antitumor effect compared to monotherapy by preventing transactivation between EGFR and GHRH-R in CRPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grupo de Investigación Cánceres de Origen Epitelial, Departamento de Biología de Sistemas, Campus Científico-Tecnológico, Universidad de Alcalá, 28805 Madrid, Spain.
- Unidad de Bioquímica y Biología Molecular, Departamento de Biología de Sistemas, Campus Científico-Tecnológico, Universidad de Alcalá, 28805 Madrid, Spain.
- Unidad de Biología Celular, Departamento de Biomedicina y Biotecnología, Campus Científico-Tecnológico, Universidad de Alcalá, 28805 Madrid, Spain.
- Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center, Miami, FL 33125, USA.
- Department of Pathology and Medicine, Division of Hematology/Oncology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
- Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
ORCID-Profile: M Isabel Arenas, M José Carmena, Ana M Bajo
Förderung
- Instituto de Salud Carlos III
- European Regional Development Fund
- Medical Research Service of the Department of U.S. Veterans Affairs
Zitieren
APA
Muñoz-Moreno, L., Gómez-Calcerrada, M. I., Arenas, M. I., Carmena, M. J., Prieto, J. C., Schally, A. V., & Bajo, A. M. (2024). Antagonist of Growth Hormone-Releasing Hormone Receptor MIA-690 Suppresses the Growth of Androgen-Independent Prostate Cancers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011200
Vancouver
Muñoz-Moreno L, Gómez-Calcerrada MI, Arenas MI, Carmena MJ, Prieto JC, Schally AV, et al. Antagonist of Growth Hormone-Releasing Hormone Receptor MIA-690 Suppresses the Growth of Androgen-Independent Prostate Cancers. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011200
BibTeX
@article{MuozMoreno2024,
author = {Muñoz-Moreno, Laura and Gómez-Calcerrada, M Isabel and Arenas, M Isabel and Carmena, M José and Prieto, Juan C and Schally, Andrew V and Bajo, Ana M},
title = {Antagonist of Growth Hormone-Releasing Hormone Receptor MIA-690 Suppresses the Growth of Androgen-Independent Prostate Cancers},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252011200}
}
EUVIMED